An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)

Conditions

• Coronavirus Infections
• Vaccine

Interventions

• BIOLOGICAL: CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
• OTHER: The data from volunteers from the control group

Sponsor

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products